We hope readers of Ye Olde Catalyst are enjoying a relaxing and reinvigorating week.
Most Recent Posts
A new Food and Drug Administration (FDA) infographic may help patients and their families better understand the lengthy drug development and review process, which is somewhat complicated and has many steps to ensure safety and eff
A guest post today on Forbes.com by Merck Chairman, President and CEO Ken Frazier puts the fiscal cliff and medical innovation in an i
In light of the report we just released highlighting the medicines in development for HIV/AIDS, I thought this interview with a top infectious disease researcher was worth re-posting.